| 常用名 | 琥珀酸曲格列汀 | CAS号 | 1029877-94-8 |
|---|---|---|---|
| 价格 | ¥需询单/1kg ¥需询单/1g ¥需询单/1mg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: Trelagliptin(SYR-472) is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D). IC50 value:Target: DPP4Two Phase II clinical studies have been completed with Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus. Phase III clinical studies with trelagliptin in Japan to evaluate its safety and efficacy in a once-weekly oral treatment regimen. Currently, all available DPP-4 inhibitors are dosed once-daily. A once-weekly treatment, such as trelagliptin, would provide patients with a convenient treatment alternative and has the potential to improve treatment compliance. 物理化学性质: CAS号:1029877-94-8 常用中文名:琥珀酸曲格列汀 常用英文名:Trelagliptin succinate 分子式:C22H26FN5O6 分子量:475.470 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:-20℃ |